nodes	percent_of_prediction	percent_of_DWPC	metapath
Mirabegron—ALB—Estropipate—osteoporosis	0.112	0.169	CbGbCtD
Mirabegron—SLCO1A2—Conjugated Estrogens—osteoporosis	0.103	0.155	CbGbCtD
Mirabegron—SLCO1A2—Estradiol—osteoporosis	0.09	0.136	CbGbCtD
Mirabegron—ALB—Estradiol—osteoporosis	0.0465	0.0702	CbGbCtD
Mirabegron—ABCB1—Ethinyl Estradiol—osteoporosis	0.0378	0.057	CbGbCtD
Mirabegron—CYP3A4—Estropipate—osteoporosis	0.0351	0.053	CbGbCtD
Mirabegron—CYP3A4—Calcitriol—osteoporosis	0.0351	0.053	CbGbCtD
Mirabegron—CYP2D6—Cholecalciferol—osteoporosis	0.0284	0.0429	CbGbCtD
Mirabegron—CYP3A4—Ergocalciferol—osteoporosis	0.0281	0.0423	CbGbCtD
Mirabegron—ABCB1—Conjugated Estrogens—osteoporosis	0.0277	0.0418	CbGbCtD
Mirabegron—ABCB1—Estradiol—osteoporosis	0.0243	0.0367	CbGbCtD
Mirabegron—CYP3A4—Raloxifene—osteoporosis	0.0234	0.0353	CbGbCtD
Mirabegron—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0226	0.0341	CbGbCtD
Mirabegron—CYP3A4—Cholecalciferol—osteoporosis	0.0181	0.0273	CbGbCtD
Mirabegron—CYP3A4—Conjugated Estrogens—osteoporosis	0.0166	0.025	CbGbCtD
Mirabegron—CYP3A4—Estradiol—osteoporosis	0.0146	0.022	CbGbCtD
Mirabegron—Breast disorder—Estradiol—osteoporosis	0.00051	0.00171	CcSEcCtD
Mirabegron—Sinusitis—Conjugated Estrogens—osteoporosis	0.00051	0.00171	CcSEcCtD
Mirabegron—Skin disorder—Estropipate—osteoporosis	0.00051	0.00171	CcSEcCtD
Mirabegron—Infection—Raloxifene—osteoporosis	0.000505	0.00169	CcSEcCtD
Mirabegron—Nasopharyngitis—Estradiol—osteoporosis	0.000505	0.00169	CcSEcCtD
Mirabegron—Back pain—Ethinyl Estradiol—osteoporosis	0.000504	0.00169	CcSEcCtD
Mirabegron—Dry mouth—Calcitriol—osteoporosis	0.000502	0.00169	CcSEcCtD
Mirabegron—Urinary tract disorder—Zoledronate—osteoporosis	0.0005	0.00168	CcSEcCtD
Mirabegron—Infection—Ibandronate—osteoporosis	0.0005	0.00168	CcSEcCtD
Mirabegron—Gastritis—Estradiol—osteoporosis	0.0005	0.00168	CcSEcCtD
Mirabegron—Connective tissue disorder—Zoledronate—osteoporosis	0.000498	0.00167	CcSEcCtD
Mirabegron—Alanine aminotransferase increased—Estradiol—osteoporosis	0.000498	0.00167	CcSEcCtD
Mirabegron—Urethral disorder—Zoledronate—osteoporosis	0.000497	0.00167	CcSEcCtD
Mirabegron—Gastrointestinal pain—Etidronic acid—osteoporosis	0.000496	0.00166	CcSEcCtD
Mirabegron—Skin disorder—Raloxifene—osteoporosis	0.000494	0.00166	CcSEcCtD
Mirabegron—Back pain—Risedronate—osteoporosis	0.000491	0.00165	CcSEcCtD
Mirabegron—Abdominal distension—Estradiol—osteoporosis	0.000491	0.00165	CcSEcCtD
Mirabegron—Rhinitis—Conjugated Estrogens—osteoporosis	0.000489	0.00164	CcSEcCtD
Mirabegron—Skin disorder—Ibandronate—osteoporosis	0.000489	0.00164	CcSEcCtD
Mirabegron—Influenza—Estradiol—osteoporosis	0.000488	0.00164	CcSEcCtD
Mirabegron—Nausea—Ergocalciferol—osteoporosis	0.000485	0.00163	CcSEcCtD
Mirabegron—Urticaria—Etidronic acid—osteoporosis	0.000482	0.00162	CcSEcCtD
Mirabegron—Abdominal pain—Etidronic acid—osteoporosis	0.000479	0.00161	CcSEcCtD
Mirabegron—Skin disorder—Calcitriol—osteoporosis	0.000478	0.0016	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Estropipate—osteoporosis	0.000478	0.0016	CcSEcCtD
Mirabegron—Eye disorder—Zoledronate—osteoporosis	0.000474	0.00159	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Alendronate—osteoporosis	0.000471	0.00158	CcSEcCtD
Mirabegron—Cardiac disorder—Zoledronate—osteoporosis	0.00047	0.00158	CcSEcCtD
Mirabegron—Back pain—Pamidronate—osteoporosis	0.000467	0.00157	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Raloxifene—osteoporosis	0.000463	0.00155	CcSEcCtD
Mirabegron—Dyspepsia—Estropipate—osteoporosis	0.000462	0.00155	CcSEcCtD
Mirabegron—Erythema multiforme—Conjugated Estrogens—osteoporosis	0.000461	0.00155	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Ibandronate—osteoporosis	0.000458	0.00154	CcSEcCtD
Mirabegron—Eye disorder—Conjugated Estrogens—osteoporosis	0.000456	0.00153	CcSEcCtD
Mirabegron—Dyspepsia—Alendronate—osteoporosis	0.000455	0.00153	CcSEcCtD
Mirabegron—Upper respiratory tract infection—Estradiol—osteoporosis	0.000453	0.00152	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Estropipate—osteoporosis	0.000453	0.00152	CcSEcCtD
Mirabegron—Cardiac disorder—Conjugated Estrogens—osteoporosis	0.000453	0.00152	CcSEcCtD
Mirabegron—Fatigue—Estropipate—osteoporosis	0.000452	0.00152	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Calcitriol—osteoporosis	0.000449	0.0015	CcSEcCtD
Mirabegron—Constipation—Estropipate—osteoporosis	0.000449	0.0015	CcSEcCtD
Mirabegron—Dyspepsia—Raloxifene—osteoporosis	0.000447	0.0015	CcSEcCtD
Mirabegron—Dyspepsia—Ibandronate—osteoporosis	0.000443	0.00149	CcSEcCtD
Mirabegron—Constipation—Alendronate—osteoporosis	0.000442	0.00148	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Ethinyl Estradiol—osteoporosis	0.000441	0.00148	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Raloxifene—osteoporosis	0.000439	0.00147	CcSEcCtD
Mirabegron—Hypertension—Risedronate—osteoporosis	0.000439	0.00147	CcSEcCtD
Mirabegron—Infestation NOS—Estradiol—osteoporosis	0.000435	0.00146	CcSEcCtD
Mirabegron—Infestation—Estradiol—osteoporosis	0.000435	0.00146	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Ibandronate—osteoporosis	0.000434	0.00146	CcSEcCtD
Mirabegron—Fatigue—Ibandronate—osteoporosis	0.000434	0.00145	CcSEcCtD
Mirabegron—Arthralgia—Risedronate—osteoporosis	0.000432	0.00145	CcSEcCtD
Mirabegron—Constipation—Ibandronate—osteoporosis	0.00043	0.00144	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Risedronate—osteoporosis	0.000429	0.00144	CcSEcCtD
Mirabegron—Pruritus—Etidronic acid—osteoporosis	0.000429	0.00144	CcSEcCtD
Mirabegron—Gastrointestinal pain—Estropipate—osteoporosis	0.000429	0.00144	CcSEcCtD
Mirabegron—Back pain—Zoledronate—osteoporosis	0.000427	0.00143	CcSEcCtD
Mirabegron—Dry mouth—Risedronate—osteoporosis	0.000423	0.00142	CcSEcCtD
Mirabegron—Urinary tract infection—Estradiol—osteoporosis	0.000423	0.00142	CcSEcCtD
Mirabegron—Gastrointestinal pain—Alendronate—osteoporosis	0.000423	0.00142	CcSEcCtD
Mirabegron—Infection—Ethinyl Estradiol—osteoporosis	0.000422	0.00142	CcSEcCtD
Mirabegron—Constipation—Calcitriol—osteoporosis	0.000421	0.00141	CcSEcCtD
Mirabegron—Hypertension—Pamidronate—osteoporosis	0.000417	0.0014	CcSEcCtD
Mirabegron—Urticaria—Estropipate—osteoporosis	0.000417	0.0014	CcSEcCtD
Mirabegron—Vision blurred—Zoledronate—osteoporosis	0.000416	0.00139	CcSEcCtD
Mirabegron—Gastrointestinal pain—Raloxifene—osteoporosis	0.000416	0.00139	CcSEcCtD
Mirabegron—Diarrhoea—Etidronic acid—osteoporosis	0.000415	0.00139	CcSEcCtD
Mirabegron—Abdominal pain—Estropipate—osteoporosis	0.000415	0.00139	CcSEcCtD
Mirabegron—Skin disorder—Ethinyl Estradiol—osteoporosis	0.000413	0.00139	CcSEcCtD
Mirabegron—Infection—Risedronate—osteoporosis	0.000412	0.00138	CcSEcCtD
Mirabegron—Gastrointestinal pain—Ibandronate—osteoporosis	0.000411	0.00138	CcSEcCtD
Mirabegron—Arthralgia—Pamidronate—osteoporosis	0.000411	0.00138	CcSEcCtD
Mirabegron—Back pain—Conjugated Estrogens—osteoporosis	0.000411	0.00138	CcSEcCtD
Mirabegron—Urticaria—Alendronate—osteoporosis	0.00041	0.00138	CcSEcCtD
Mirabegron—Abdominal pain—Alendronate—osteoporosis	0.000408	0.00137	CcSEcCtD
Mirabegron—Sinusitis—Estradiol—osteoporosis	0.000408	0.00137	CcSEcCtD
Mirabegron—Skin disorder—Risedronate—osteoporosis	0.000403	0.00135	CcSEcCtD
Mirabegron—Gastrointestinal pain—Calcitriol—osteoporosis	0.000403	0.00135	CcSEcCtD
Mirabegron—Abdominal pain—Raloxifene—osteoporosis	0.000402	0.00135	CcSEcCtD
Mirabegron—Vision blurred—Conjugated Estrogens—osteoporosis	0.0004	0.00134	CcSEcCtD
Mirabegron—Urticaria—Ibandronate—osteoporosis	0.0004	0.00134	CcSEcCtD
Mirabegron—Abdominal pain—Ibandronate—osteoporosis	0.000398	0.00133	CcSEcCtD
Mirabegron—Infection—Pamidronate—osteoporosis	0.000392	0.00131	CcSEcCtD
Mirabegron—Rhinitis—Estradiol—osteoporosis	0.000391	0.00131	CcSEcCtD
Mirabegron—Urticaria—Calcitriol—osteoporosis	0.000391	0.00131	CcSEcCtD
Mirabegron—Palpitations—Zoledronate—osteoporosis	0.00039	0.00131	CcSEcCtD
Mirabegron—Abdominal pain—Calcitriol—osteoporosis	0.000389	0.00131	CcSEcCtD
Mirabegron—Urinary tract disorder—Estradiol—osteoporosis	0.000386	0.00129	CcSEcCtD
Mirabegron—Tachycardia—Pamidronate—osteoporosis	0.000385	0.00129	CcSEcCtD
Mirabegron—Connective tissue disorder—Estradiol—osteoporosis	0.000384	0.00129	CcSEcCtD
Mirabegron—Urethral disorder—Estradiol—osteoporosis	0.000383	0.00128	CcSEcCtD
Mirabegron—Rash—Etidronic acid—osteoporosis	0.000382	0.00128	CcSEcCtD
Mirabegron—Dermatitis—Etidronic acid—osteoporosis	0.000382	0.00128	CcSEcCtD
Mirabegron—Hypertension—Zoledronate—osteoporosis	0.000381	0.00128	CcSEcCtD
Mirabegron—Headache—Etidronic acid—osteoporosis	0.00038	0.00127	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000378	0.00127	CcSEcCtD
Mirabegron—Asthenia—Estropipate—osteoporosis	0.000376	0.00126	CcSEcCtD
Mirabegron—Arthralgia—Zoledronate—osteoporosis	0.000376	0.00126	CcSEcCtD
Mirabegron—Palpitations—Conjugated Estrogens—osteoporosis	0.000375	0.00126	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000373	0.00125	CcSEcCtD
Mirabegron—Pruritus—Estropipate—osteoporosis	0.000371	0.00124	CcSEcCtD
Mirabegron—Asthenia—Alendronate—osteoporosis	0.000371	0.00124	CcSEcCtD
Mirabegron—Erythema multiforme—Estradiol—osteoporosis	0.000369	0.00124	CcSEcCtD
Mirabegron—Dry mouth—Zoledronate—osteoporosis	0.000367	0.00123	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000367	0.00123	CcSEcCtD
Mirabegron—Fatigue—Ethinyl Estradiol—osteoporosis	0.000367	0.00123	CcSEcCtD
Mirabegron—Pruritus—Alendronate—osteoporosis	0.000366	0.00123	CcSEcCtD
Mirabegron—Dyspepsia—Risedronate—osteoporosis	0.000365	0.00122	CcSEcCtD
Mirabegron—Eye disorder—Estradiol—osteoporosis	0.000365	0.00122	CcSEcCtD
Mirabegron—Constipation—Ethinyl Estradiol—osteoporosis	0.000364	0.00122	CcSEcCtD
Mirabegron—Cardiac disorder—Estradiol—osteoporosis	0.000362	0.00122	CcSEcCtD
Mirabegron—Arthralgia—Conjugated Estrogens—osteoporosis	0.000362	0.00121	CcSEcCtD
Mirabegron—Asthenia—Ibandronate—osteoporosis	0.000361	0.00121	CcSEcCtD
Mirabegron—Nausea—Etidronic acid—osteoporosis	0.00036	0.00121	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000359	0.0012	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000359	0.0012	CcSEcCtD
Mirabegron—Diarrhoea—Estropipate—osteoporosis	0.000359	0.0012	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Risedronate—osteoporosis	0.000358	0.0012	CcSEcCtD
Mirabegron—Infection—Zoledronate—osteoporosis	0.000358	0.0012	CcSEcCtD
Mirabegron—Fatigue—Risedronate—osteoporosis	0.000357	0.0012	CcSEcCtD
Mirabegron—Pruritus—Ibandronate—osteoporosis	0.000356	0.00119	CcSEcCtD
Mirabegron—Constipation—Risedronate—osteoporosis	0.000355	0.00119	CcSEcCtD
Mirabegron—Diarrhoea—Alendronate—osteoporosis	0.000354	0.00119	CcSEcCtD
Mirabegron—Asthenia—Calcitriol—osteoporosis	0.000353	0.00119	CcSEcCtD
Mirabegron—Tachycardia—Zoledronate—osteoporosis	0.000351	0.00118	CcSEcCtD
Mirabegron—Skin disorder—Zoledronate—osteoporosis	0.00035	0.00117	CcSEcCtD
Mirabegron—Pruritus—Calcitriol—osteoporosis	0.000348	0.00117	CcSEcCtD
Mirabegron—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000348	0.00117	CcSEcCtD
Mirabegron—Diarrhoea—Raloxifene—osteoporosis	0.000348	0.00117	CcSEcCtD
Mirabegron—Dyspepsia—Pamidronate—osteoporosis	0.000347	0.00116	CcSEcCtD
Mirabegron—Dizziness—Estropipate—osteoporosis	0.000347	0.00116	CcSEcCtD
Mirabegron—Infection—Conjugated Estrogens—osteoporosis	0.000344	0.00116	CcSEcCtD
Mirabegron—Diarrhoea—Ibandronate—osteoporosis	0.000344	0.00115	CcSEcCtD
Mirabegron—Dizziness—Alendronate—osteoporosis	0.000342	0.00115	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Pamidronate—osteoporosis	0.00034	0.00114	CcSEcCtD
Mirabegron—Fatigue—Pamidronate—osteoporosis	0.00034	0.00114	CcSEcCtD
Mirabegron—Gastrointestinal pain—Risedronate—osteoporosis	0.000339	0.00114	CcSEcCtD
Mirabegron—Tachycardia—Conjugated Estrogens—osteoporosis	0.000338	0.00113	CcSEcCtD
Mirabegron—Urticaria—Ethinyl Estradiol—osteoporosis	0.000338	0.00113	CcSEcCtD
Mirabegron—Constipation—Pamidronate—osteoporosis	0.000337	0.00113	CcSEcCtD
Mirabegron—Diarrhoea—Calcitriol—osteoporosis	0.000337	0.00113	CcSEcCtD
Mirabegron—Skin disorder—Conjugated Estrogens—osteoporosis	0.000337	0.00113	CcSEcCtD
Mirabegron—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000336	0.00113	CcSEcCtD
Mirabegron—Dizziness—Raloxifene—osteoporosis	0.000336	0.00113	CcSEcCtD
Mirabegron—Dizziness—Ibandronate—osteoporosis	0.000333	0.00112	CcSEcCtD
Mirabegron—Rash—Estropipate—osteoporosis	0.000331	0.00111	CcSEcCtD
Mirabegron—Dermatitis—Estropipate—osteoporosis	0.00033	0.00111	CcSEcCtD
Mirabegron—Urticaria—Risedronate—osteoporosis	0.000329	0.0011	CcSEcCtD
Mirabegron—Back pain—Estradiol—osteoporosis	0.000329	0.0011	CcSEcCtD
Mirabegron—Headache—Estropipate—osteoporosis	0.000329	0.0011	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000328	0.0011	CcSEcCtD
Mirabegron—Abdominal pain—Risedronate—osteoporosis	0.000328	0.0011	CcSEcCtD
Mirabegron—Rash—Alendronate—osteoporosis	0.000326	0.00109	CcSEcCtD
Mirabegron—Dermatitis—Alendronate—osteoporosis	0.000325	0.00109	CcSEcCtD
Mirabegron—Headache—Alendronate—osteoporosis	0.000324	0.00109	CcSEcCtD
Mirabegron—Gastrointestinal pain—Pamidronate—osteoporosis	0.000322	0.00108	CcSEcCtD
Mirabegron—Rash—Raloxifene—osteoporosis	0.00032	0.00107	CcSEcCtD
Mirabegron—Dermatitis—Raloxifene—osteoporosis	0.00032	0.00107	CcSEcCtD
Mirabegron—Headache—Raloxifene—osteoporosis	0.000318	0.00107	CcSEcCtD
Mirabegron—Rash—Ibandronate—osteoporosis	0.000317	0.00106	CcSEcCtD
Mirabegron—Dermatitis—Ibandronate—osteoporosis	0.000317	0.00106	CcSEcCtD
Mirabegron—Dyspepsia—Zoledronate—osteoporosis	0.000317	0.00106	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000316	0.00106	CcSEcCtD
Mirabegron—Headache—Ibandronate—osteoporosis	0.000315	0.00106	CcSEcCtD
Mirabegron—Nausea—Estropipate—osteoporosis	0.000312	0.00105	CcSEcCtD
Mirabegron—Abdominal pain—Pamidronate—osteoporosis	0.000312	0.00105	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000311	0.00104	CcSEcCtD
Mirabegron—Rash—Calcitriol—osteoporosis	0.00031	0.00104	CcSEcCtD
Mirabegron—Fatigue—Zoledronate—osteoporosis	0.00031	0.00104	CcSEcCtD
Mirabegron—Dermatitis—Calcitriol—osteoporosis	0.00031	0.00104	CcSEcCtD
Mirabegron—Headache—Calcitriol—osteoporosis	0.000308	0.00103	CcSEcCtD
Mirabegron—Constipation—Zoledronate—osteoporosis	0.000308	0.00103	CcSEcCtD
Mirabegron—Nausea—Alendronate—osteoporosis	0.000307	0.00103	CcSEcCtD
Mirabegron—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000305	0.00102	CcSEcCtD
Mirabegron—Asthenia—Ethinyl Estradiol—osteoporosis	0.000305	0.00102	CcSEcCtD
Mirabegron—Nausea—Raloxifene—osteoporosis	0.000302	0.00101	CcSEcCtD
Mirabegron—Pruritus—Ethinyl Estradiol—osteoporosis	0.000301	0.00101	CcSEcCtD
Mirabegron—Palpitations—Estradiol—osteoporosis	0.0003	0.00101	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000299	0.001	CcSEcCtD
Mirabegron—Fatigue—Conjugated Estrogens—osteoporosis	0.000299	0.001	CcSEcCtD
Mirabegron—Nausea—Ibandronate—osteoporosis	0.000299	0.001	CcSEcCtD
Mirabegron—Asthenia—Risedronate—osteoporosis	0.000297	0.000998	CcSEcCtD
Mirabegron—Constipation—Conjugated Estrogens—osteoporosis	0.000296	0.000994	CcSEcCtD
Mirabegron—Gastrointestinal pain—Zoledronate—osteoporosis	0.000294	0.000987	CcSEcCtD
Mirabegron—Hypertension—Estradiol—osteoporosis	0.000293	0.000984	CcSEcCtD
Mirabegron—Pruritus—Risedronate—osteoporosis	0.000293	0.000984	CcSEcCtD
Mirabegron—Nausea—Calcitriol—osteoporosis	0.000293	0.000981	CcSEcCtD
Mirabegron—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000291	0.000976	CcSEcCtD
Mirabegron—Arthralgia—Estradiol—osteoporosis	0.000289	0.000971	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000287	0.000964	CcSEcCtD
Mirabegron—Urticaria—Zoledronate—osteoporosis	0.000286	0.000959	CcSEcCtD
Mirabegron—Abdominal pain—Zoledronate—osteoporosis	0.000285	0.000955	CcSEcCtD
Mirabegron—Diarrhoea—Risedronate—osteoporosis	0.000284	0.000951	CcSEcCtD
Mirabegron—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000283	0.000951	CcSEcCtD
Mirabegron—Dry mouth—Estradiol—osteoporosis	0.000283	0.000949	CcSEcCtD
Mirabegron—Asthenia—Pamidronate—osteoporosis	0.000283	0.000948	CcSEcCtD
Mirabegron—Dizziness—Ethinyl Estradiol—osteoporosis	0.000281	0.000943	CcSEcCtD
Mirabegron—Pruritus—Pamidronate—osteoporosis	0.000279	0.000935	CcSEcCtD
Mirabegron—Infection—Estradiol—osteoporosis	0.000276	0.000924	CcSEcCtD
Mirabegron—Urticaria—Conjugated Estrogens—osteoporosis	0.000275	0.000924	CcSEcCtD
Mirabegron—Dizziness—Risedronate—osteoporosis	0.000274	0.00092	CcSEcCtD
Mirabegron—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000274	0.000919	CcSEcCtD
Mirabegron—Tachycardia—Estradiol—osteoporosis	0.000271	0.000908	CcSEcCtD
Mirabegron—Diarrhoea—Pamidronate—osteoporosis	0.00027	0.000904	CcSEcCtD
Mirabegron—Skin disorder—Estradiol—osteoporosis	0.000269	0.000904	CcSEcCtD
Mirabegron—Rash—Ethinyl Estradiol—osteoporosis	0.000268	0.000899	CcSEcCtD
Mirabegron—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000268	0.000898	CcSEcCtD
Mirabegron—Headache—Ethinyl Estradiol—osteoporosis	0.000266	0.000894	CcSEcCtD
Mirabegron—Rash—Risedronate—osteoporosis	0.000261	0.000877	CcSEcCtD
Mirabegron—Dermatitis—Risedronate—osteoporosis	0.000261	0.000876	CcSEcCtD
Mirabegron—Dizziness—Pamidronate—osteoporosis	0.000261	0.000874	CcSEcCtD
Mirabegron—Headache—Risedronate—osteoporosis	0.00026	0.000871	CcSEcCtD
Mirabegron—Asthenia—Zoledronate—osteoporosis	0.000258	0.000866	CcSEcCtD
Mirabegron—Pruritus—Zoledronate—osteoporosis	0.000255	0.000854	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000253	0.000848	CcSEcCtD
Mirabegron—Nausea—Ethinyl Estradiol—osteoporosis	0.000253	0.000847	CcSEcCtD
Mirabegron—Asthenia—Conjugated Estrogens—osteoporosis	0.000249	0.000834	CcSEcCtD
Mirabegron—Rash—Pamidronate—osteoporosis	0.000248	0.000834	CcSEcCtD
Mirabegron—Dermatitis—Pamidronate—osteoporosis	0.000248	0.000833	CcSEcCtD
Mirabegron—Headache—Pamidronate—osteoporosis	0.000247	0.000828	CcSEcCtD
Mirabegron—Diarrhoea—Zoledronate—osteoporosis	0.000246	0.000826	CcSEcCtD
Mirabegron—Nausea—Risedronate—osteoporosis	0.000246	0.000826	CcSEcCtD
Mirabegron—Pruritus—Conjugated Estrogens—osteoporosis	0.000245	0.000823	CcSEcCtD
Mirabegron—Dyspepsia—Estradiol—osteoporosis	0.000244	0.000819	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Estradiol—osteoporosis	0.00024	0.000803	CcSEcCtD
Mirabegron—Fatigue—Estradiol—osteoporosis	0.000239	0.000802	CcSEcCtD
Mirabegron—Dizziness—Zoledronate—osteoporosis	0.000238	0.000799	CcSEcCtD
Mirabegron—Constipation—Estradiol—osteoporosis	0.000237	0.000796	CcSEcCtD
Mirabegron—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000237	0.000796	CcSEcCtD
Mirabegron—Nausea—Pamidronate—osteoporosis	0.000234	0.000785	CcSEcCtD
Mirabegron—Dizziness—Conjugated Estrogens—osteoporosis	0.000229	0.000769	CcSEcCtD
Mirabegron—Rash—Zoledronate—osteoporosis	0.000227	0.000761	CcSEcCtD
Mirabegron—Gastrointestinal pain—Estradiol—osteoporosis	0.000227	0.000761	CcSEcCtD
Mirabegron—Dermatitis—Zoledronate—osteoporosis	0.000227	0.000761	CcSEcCtD
Mirabegron—Headache—Zoledronate—osteoporosis	0.000226	0.000756	CcSEcCtD
Mirabegron—Urticaria—Estradiol—osteoporosis	0.00022	0.000739	CcSEcCtD
Mirabegron—Abdominal pain—Estradiol—osteoporosis	0.000219	0.000736	CcSEcCtD
Mirabegron—Rash—Conjugated Estrogens—osteoporosis	0.000219	0.000733	CcSEcCtD
Mirabegron—Dermatitis—Conjugated Estrogens—osteoporosis	0.000218	0.000732	CcSEcCtD
Mirabegron—Headache—Conjugated Estrogens—osteoporosis	0.000217	0.000728	CcSEcCtD
Mirabegron—Nausea—Zoledronate—osteoporosis	0.000214	0.000717	CcSEcCtD
Mirabegron—Nausea—Conjugated Estrogens—osteoporosis	0.000206	0.000691	CcSEcCtD
Mirabegron—Asthenia—Estradiol—osteoporosis	0.000199	0.000668	CcSEcCtD
Mirabegron—Pruritus—Estradiol—osteoporosis	0.000196	0.000658	CcSEcCtD
Mirabegron—Diarrhoea—Estradiol—osteoporosis	0.00019	0.000637	CcSEcCtD
Mirabegron—Dizziness—Estradiol—osteoporosis	0.000183	0.000615	CcSEcCtD
Mirabegron—Rash—Estradiol—osteoporosis	0.000175	0.000587	CcSEcCtD
Mirabegron—Dermatitis—Estradiol—osteoporosis	0.000175	0.000586	CcSEcCtD
Mirabegron—Headache—Estradiol—osteoporosis	0.000174	0.000583	CcSEcCtD
Mirabegron—Nausea—Estradiol—osteoporosis	0.000165	0.000553	CcSEcCtD
Mirabegron—BCHE—Metabolism—FDPS—osteoporosis	7.35e-05	0.00189	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—PKM—osteoporosis	7.35e-05	0.00189	CbGpPWpGaD
Mirabegron—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	7.34e-05	0.00189	CbGpPWpGaD
Mirabegron—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—osteoporosis	7.33e-05	0.00189	CbGpPWpGaD
Mirabegron—CYP3A4—Metapathway biotransformation—CYP27A1—osteoporosis	7.32e-05	0.00188	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—ATIC—osteoporosis	7.26e-05	0.00187	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—PNP—osteoporosis	7.26e-05	0.00187	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—MGLL—osteoporosis	7.25e-05	0.00186	CbGpPWpGaD
Mirabegron—BCHE—Neuronal System—ADCY5—osteoporosis	7.19e-05	0.00185	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—WNT1—osteoporosis	7.16e-05	0.00184	CbGpPWpGaD
Mirabegron—ADRB3—GPCR downstream signaling—PTHLH—osteoporosis	7.13e-05	0.00183	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—MGLL—osteoporosis	6.98e-05	0.0018	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—PGLS—osteoporosis	6.97e-05	0.00179	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—GPD2—osteoporosis	6.97e-05	0.00179	CbGpPWpGaD
Mirabegron—ALB—Folate Metabolism—IL1B—osteoporosis	6.93e-05	0.00178	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—LRP5—osteoporosis	6.81e-05	0.00175	CbGpPWpGaD
Mirabegron—ALB—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	6.77e-05	0.00174	CbGpPWpGaD
Mirabegron—CYP2D6—Phase 1 - Functionalization of compounds—POMC—osteoporosis	6.74e-05	0.00173	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—PLEK—osteoporosis	6.63e-05	0.00171	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—ANXA2—osteoporosis	6.63e-05	0.00171	CbGpPWpGaD
Mirabegron—ALB—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	6.6e-05	0.0017	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—LRP6—osteoporosis	6.52e-05	0.00168	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—PTHLH—osteoporosis	6.47e-05	0.00167	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—osteoporosis	6.41e-05	0.00165	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—PNP—osteoporosis	6.37e-05	0.00164	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—ATIC—osteoporosis	6.37e-05	0.00164	CbGpPWpGaD
Mirabegron—ADRB3—GPCR downstream signaling—CALCA—osteoporosis	6.28e-05	0.00161	CbGpPWpGaD
Mirabegron—ALB—Vitamin B12 Metabolism—TNF—osteoporosis	6.18e-05	0.00159	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—CA2—osteoporosis	6.17e-05	0.00159	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—OXCT1—osteoporosis	6.17e-05	0.00159	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—MGLL—osteoporosis	6.02e-05	0.00155	CbGpPWpGaD
Mirabegron—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—osteoporosis	6e-05	0.00154	CbGpPWpGaD
Mirabegron—CYP2D6—Biological oxidations—CYP19A1—osteoporosis	5.96e-05	0.00153	CbGpPWpGaD
Mirabegron—CYP2D6—Metapathway biotransformation—CYP19A1—osteoporosis	5.88e-05	0.00151	CbGpPWpGaD
Mirabegron—ADRB3—GPCR ligand binding—POMC—osteoporosis	5.81e-05	0.00149	CbGpPWpGaD
Mirabegron—ALB—Transmembrane transport of small molecules—ANXA2—osteoporosis	5.74e-05	0.00148	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—TLN1—osteoporosis	5.72e-05	0.00147	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—CALCA—osteoporosis	5.7e-05	0.00147	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	5.67e-05	0.00146	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—VCL—osteoporosis	5.64e-05	0.00145	CbGpPWpGaD
Mirabegron—ALB—Selenium Micronutrient Network—IL1B—osteoporosis	5.5e-05	0.00142	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—TLN1—osteoporosis	5.5e-05	0.00142	CbGpPWpGaD
Mirabegron—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	5.44e-05	0.0014	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—CA2—osteoporosis	5.42e-05	0.00139	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—OXCT1—osteoporosis	5.42e-05	0.00139	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—MGLL—osteoporosis	5.28e-05	0.00136	CbGpPWpGaD
Mirabegron—ALB—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	5.28e-05	0.00136	CbGpPWpGaD
Mirabegron—ABCB1—Allograft Rejection—IL1B—osteoporosis	5.26e-05	0.00135	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—IDH2—osteoporosis	5.12e-05	0.00132	CbGpPWpGaD
Mirabegron—ABCB1—Transmembrane transport of small molecules—ANXA2—osteoporosis	5.03e-05	0.00129	CbGpPWpGaD
Mirabegron—ALB—Folate Metabolism—TNF—osteoporosis	5.03e-05	0.00129	CbGpPWpGaD
Mirabegron—ALB—Vitamin B12 Metabolism—IL6—osteoporosis	4.99e-05	0.00128	CbGpPWpGaD
Mirabegron—BCHE—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	4.98e-05	0.00128	CbGpPWpGaD
Mirabegron—BCHE—Metabolism of proteins—ACE—osteoporosis	4.84e-05	0.00125	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—CYP27A1—osteoporosis	4.81e-05	0.00124	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—P4HB—osteoporosis	4.74e-05	0.00122	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—RAP1A—osteoporosis	4.71e-05	0.00121	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—ACP5—osteoporosis	4.68e-05	0.0012	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	4.62e-05	0.00119	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—PTH—osteoporosis	4.62e-05	0.00119	CbGpPWpGaD
Mirabegron—ALB—Platelet degranulation—TGFB1—osteoporosis	4.61e-05	0.00119	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—RAP1A—osteoporosis	4.54e-05	0.00117	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—CNR2—osteoporosis	4.5e-05	0.00116	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—IDH2—osteoporosis	4.49e-05	0.00115	CbGpPWpGaD
Mirabegron—ALB—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	4.49e-05	0.00115	CbGpPWpGaD
Mirabegron—ADRB3—GPCR downstream signaling—ADCY5—osteoporosis	4.46e-05	0.00115	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—NFATC1—osteoporosis	4.42e-05	0.00114	CbGpPWpGaD
Mirabegron—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	4.41e-05	0.00113	CbGpPWpGaD
Mirabegron—SLCO1A2—Transmembrane transport of small molecules—ADCY5—osteoporosis	4.41e-05	0.00113	CbGpPWpGaD
Mirabegron—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—osteoporosis	4.4e-05	0.00113	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—DKK1—osteoporosis	4.39e-05	0.00113	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—TPI1—osteoporosis	4.35e-05	0.00112	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—FGA—osteoporosis	4.27e-05	0.0011	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—WNT1—osteoporosis	4.23e-05	0.00109	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—CYP27A1—osteoporosis	4.22e-05	0.00109	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—FGA—osteoporosis	4.11e-05	0.00106	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—ACP5—osteoporosis	4.11e-05	0.00106	CbGpPWpGaD
Mirabegron—ALB—Metabolism—PKM—osteoporosis	4.09e-05	0.00105	CbGpPWpGaD
Mirabegron—ALB—Metabolism—FDPS—osteoporosis	4.09e-05	0.00105	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—P4HB—osteoporosis	4.09e-05	0.00105	CbGpPWpGaD
Mirabegron—ABCB1—Allograft Rejection—TGFB1—osteoporosis	4.08e-05	0.00105	CbGpPWpGaD
Mirabegron—ALB—Folate Metabolism—IL6—osteoporosis	4.06e-05	0.00104	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—ADCY5—osteoporosis	4.05e-05	0.00104	CbGpPWpGaD
Mirabegron—BCHE—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	4.05e-05	0.00104	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—GAPDH—osteoporosis	4.01e-05	0.00103	CbGpPWpGaD
Mirabegron—ALB—Selenium Micronutrient Network—TNF—osteoporosis	3.99e-05	0.00103	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—RAP1A—osteoporosis	3.91e-05	0.00101	CbGpPWpGaD
Mirabegron—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	3.9e-05	0.001	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—FGB—osteoporosis	3.89e-05	0.001	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	3.88e-05	0.000999	CbGpPWpGaD
Mirabegron—ALB—Metabolism—GPD2—osteoporosis	3.88e-05	0.000998	CbGpPWpGaD
Mirabegron—ALB—Metabolism—PGLS—osteoporosis	3.88e-05	0.000998	CbGpPWpGaD
Mirabegron—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	3.84e-05	0.000988	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—PTHLH—osteoporosis	3.82e-05	0.000984	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—BMP2—osteoporosis	3.82e-05	0.000984	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—TPI1—osteoporosis	3.82e-05	0.000982	CbGpPWpGaD
Mirabegron—ABCB1—Allograft Rejection—TNF—osteoporosis	3.81e-05	0.000981	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—FGB—osteoporosis	3.74e-05	0.000963	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—PSMA5—osteoporosis	3.61e-05	0.000929	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—PSMA2—osteoporosis	3.61e-05	0.000929	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—P4HB—osteoporosis	3.59e-05	0.000923	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—PKM—osteoporosis	3.58e-05	0.000922	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—FDPS—osteoporosis	3.58e-05	0.000922	CbGpPWpGaD
Mirabegron—CYP2D6—Biological oxidations—POMC—osteoporosis	3.58e-05	0.000921	CbGpPWpGaD
Mirabegron—ALB—Metabolism—ATIC—osteoporosis	3.55e-05	0.000912	CbGpPWpGaD
Mirabegron—ALB—Metabolism—PNP—osteoporosis	3.55e-05	0.000912	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—GAPDH—osteoporosis	3.52e-05	0.000906	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—RAP1A—osteoporosis	3.43e-05	0.000882	CbGpPWpGaD
Mirabegron—ALB—Platelet activation, signaling and aggregation—IGF1—osteoporosis	3.41e-05	0.000878	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	3.41e-05	0.000877	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—PGLS—osteoporosis	3.4e-05	0.000874	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—GPD2—osteoporosis	3.4e-05	0.000874	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—FDPS—osteoporosis	3.38e-05	0.000869	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—PKM—osteoporosis	3.38e-05	0.000869	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—CALCA—osteoporosis	3.37e-05	0.000866	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	3.36e-05	0.000865	CbGpPWpGaD
Mirabegron—ADRB3—GPCR downstream signaling—POMC—osteoporosis	3.28e-05	0.000845	CbGpPWpGaD
Mirabegron—ALB—Selenium Micronutrient Network—IL6—osteoporosis	3.22e-05	0.000829	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—GPD2—osteoporosis	3.2e-05	0.000824	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—PGLS—osteoporosis	3.2e-05	0.000824	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—ENO1—osteoporosis	3.16e-05	0.000813	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—PSMA2—osteoporosis	3.11e-05	0.000801	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—PSMA5—osteoporosis	3.11e-05	0.000801	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—ATIC—osteoporosis	3.11e-05	0.000799	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—PNP—osteoporosis	3.11e-05	0.000799	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—KL—osteoporosis	3.06e-05	0.000786	CbGpPWpGaD
Mirabegron—ALB—Metabolism—OXCT1—osteoporosis	3.02e-05	0.000776	CbGpPWpGaD
Mirabegron—ALB—Metabolism—CA2—osteoporosis	3.02e-05	0.000776	CbGpPWpGaD
Mirabegron—BCHE—Metabolism of proteins—LEP—osteoporosis	3.01e-05	0.000774	CbGpPWpGaD
Mirabegron—BCHE—Metabolism of lipids and lipoproteins—POMC—osteoporosis	2.99e-05	0.000769	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—POMC—osteoporosis	2.98e-05	0.000767	CbGpPWpGaD
Mirabegron—ALB—Metabolism—MGLL—osteoporosis	2.94e-05	0.000756	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—ATIC—osteoporosis	2.93e-05	0.000753	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—PNP—osteoporosis	2.93e-05	0.000753	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—IL6R—osteoporosis	2.91e-05	0.000748	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—ENO1—osteoporosis	2.77e-05	0.000713	CbGpPWpGaD
Mirabegron—ALB—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2.77e-05	0.000713	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—PSMA2—osteoporosis	2.73e-05	0.000703	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—PSMA5—osteoporosis	2.73e-05	0.000703	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—OXCT1—osteoporosis	2.64e-05	0.00068	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—CA2—osteoporosis	2.64e-05	0.00068	CbGpPWpGaD
Mirabegron—BCHE—Metabolism of proteins—POMC—osteoporosis	2.58e-05	0.000665	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—MGLL—osteoporosis	2.58e-05	0.000662	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—CYP19A1—osteoporosis	2.53e-05	0.00065	CbGpPWpGaD
Mirabegron—ALB—Metabolism—IDH2—osteoporosis	2.5e-05	0.000643	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—CA2—osteoporosis	2.49e-05	0.000641	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—OXCT1—osteoporosis	2.49e-05	0.000641	CbGpPWpGaD
Mirabegron—BCHE—Metabolism of proteins—IGF1—osteoporosis	2.49e-05	0.00064	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—MGLL—osteoporosis	2.43e-05	0.000624	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—ADCY5—osteoporosis	2.39e-05	0.000616	CbGpPWpGaD
Mirabegron—ALB—Metabolism—CYP27A1—osteoporosis	2.35e-05	0.000604	CbGpPWpGaD
Mirabegron—CYP3A4—Biological oxidations—POMC—osteoporosis	2.34e-05	0.000602	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—SPP1—osteoporosis	2.32e-05	0.000596	CbGpPWpGaD
Mirabegron—ALB—Metabolism—ACP5—osteoporosis	2.29e-05	0.000588	CbGpPWpGaD
Mirabegron—ALB—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	2.26e-05	0.000581	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—CYP19A1—osteoporosis	2.22e-05	0.00057	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PKM—osteoporosis	2.21e-05	0.000568	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—FDPS—osteoporosis	2.21e-05	0.000568	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—IDH2—osteoporosis	2.19e-05	0.000563	CbGpPWpGaD
Mirabegron—ALB—Transmembrane transport of small molecules—ADCY5—osteoporosis	2.15e-05	0.000554	CbGpPWpGaD
Mirabegron—ALB—Metabolism—TPI1—osteoporosis	2.13e-05	0.000547	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—IRS2—osteoporosis	2.1e-05	0.000539	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—GPD2—osteoporosis	2.09e-05	0.000539	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PGLS—osteoporosis	2.09e-05	0.000539	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—ADCY5—osteoporosis	2.06e-05	0.000531	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—IDH2—osteoporosis	2.06e-05	0.000531	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—CYP27A1—osteoporosis	2.06e-05	0.00053	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—GPX1—osteoporosis	2.06e-05	0.000529	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—LEP—osteoporosis	2.05e-05	0.000527	CbGpPWpGaD
Mirabegron—ALB—Platelet activation, signaling and aggregation—TGFB1—osteoporosis	2.05e-05	0.000527	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	2.02e-05	0.00052	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	2.02e-05	0.000518	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—ACP5—osteoporosis	2e-05	0.000515	CbGpPWpGaD
Mirabegron—ALB—Metabolism—P4HB—osteoporosis	2e-05	0.000514	CbGpPWpGaD
Mirabegron—ALB—Metabolism—GAPDH—osteoporosis	1.96e-05	0.000504	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—ESR1—osteoporosis	1.96e-05	0.000504	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—CYP27A1—osteoporosis	1.94e-05	0.000499	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PNP—osteoporosis	1.91e-05	0.000493	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—ATIC—osteoporosis	1.91e-05	0.000493	CbGpPWpGaD
Mirabegron—ALB—Metabolism—RAP1A—osteoporosis	1.91e-05	0.000491	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—MTHFR—osteoporosis	1.9e-05	0.000488	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—ACP5—osteoporosis	1.89e-05	0.000485	CbGpPWpGaD
Mirabegron—ABCB1—Transmembrane transport of small molecules—ADCY5—osteoporosis	1.89e-05	0.000485	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	1.88e-05	0.000484	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—TPI1—osteoporosis	1.86e-05	0.000479	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—IRS1—osteoporosis	1.83e-05	0.000471	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—ADCY5—osteoporosis	1.81e-05	0.000466	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—GPX1—osteoporosis	1.81e-05	0.000464	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—POMC—osteoporosis	1.76e-05	0.000453	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—IGF1—osteoporosis	1.76e-05	0.000453	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—TPI1—osteoporosis	1.75e-05	0.000451	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—P4HB—osteoporosis	1.75e-05	0.00045	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—GAPDH—osteoporosis	1.72e-05	0.000442	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—IL6R—osteoporosis	1.72e-05	0.000442	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—IGF1—osteoporosis	1.69e-05	0.000436	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—RAP1A—osteoporosis	1.67e-05	0.000431	CbGpPWpGaD
Mirabegron—ALB—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.67e-05	0.000428	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—MTHFR—osteoporosis	1.67e-05	0.000428	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—P4HB—osteoporosis	1.65e-05	0.000424	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—CA2—osteoporosis	1.63e-05	0.000419	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—OXCT1—osteoporosis	1.63e-05	0.000419	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—GAPDH—osteoporosis	1.62e-05	0.000417	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—MGLL—osteoporosis	1.59e-05	0.000408	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—RAP1A—osteoporosis	1.58e-05	0.000406	CbGpPWpGaD
Mirabegron—ALB—Metabolism—ENO1—osteoporosis	1.54e-05	0.000397	CbGpPWpGaD
Mirabegron—ALB—Metabolism—PSMA2—osteoporosis	1.52e-05	0.000391	CbGpPWpGaD
Mirabegron—ALB—Metabolism—PSMA5—osteoporosis	1.52e-05	0.000391	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—POMC—osteoporosis	1.52e-05	0.000391	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—ENO1—osteoporosis	1.35e-05	0.000348	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—IDH2—osteoporosis	1.35e-05	0.000347	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—PSMA5—osteoporosis	1.33e-05	0.000343	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—PSMA2—osteoporosis	1.33e-05	0.000343	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—POMC—osteoporosis	1.33e-05	0.000343	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—IL6—osteoporosis	1.3e-05	0.000333	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—ENO1—osteoporosis	1.27e-05	0.000328	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—CYP27A1—osteoporosis	1.27e-05	0.000326	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—PSMA2—osteoporosis	1.26e-05	0.000323	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—PSMA5—osteoporosis	1.26e-05	0.000323	CbGpPWpGaD
Mirabegron—ALB—Metabolism—CYP19A1—osteoporosis	1.23e-05	0.000318	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—ACP5—osteoporosis	1.23e-05	0.000317	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—TPI1—osteoporosis	1.15e-05	0.000295	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—CYP19A1—osteoporosis	1.08e-05	0.000278	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—P4HB—osteoporosis	1.08e-05	0.000277	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—GAPDH—osteoporosis	1.06e-05	0.000272	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—TGFB1—osteoporosis	1.06e-05	0.000271	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—RAP1A—osteoporosis	1.03e-05	0.000265	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—CYP19A1—osteoporosis	1.02e-05	0.000262	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—MYC—osteoporosis	1.02e-05	0.000262	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—TGFB1—osteoporosis	1.02e-05	0.000261	CbGpPWpGaD
Mirabegron—ALB—Metabolism—ADCY5—osteoporosis	1.01e-05	0.000259	CbGpPWpGaD
Mirabegron—ALB—Metabolism—GPX1—osteoporosis	1.01e-05	0.000259	CbGpPWpGaD
Mirabegron—ALB—Metabolism—MTHFR—osteoporosis	9.28e-06	0.000239	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—ADCY5—osteoporosis	8.84e-06	0.000227	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—GPX1—osteoporosis	8.81e-06	0.000227	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—ENO1—osteoporosis	8.34e-06	0.000214	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—ADCY5—osteoporosis	8.33e-06	0.000214	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—GPX1—osteoporosis	8.3e-06	0.000213	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PSMA5—osteoporosis	8.21e-06	0.000211	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PSMA2—osteoporosis	8.21e-06	0.000211	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—MTHFR—osteoporosis	8.13e-06	0.000209	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—MTHFR—osteoporosis	7.66e-06	0.000197	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—IL6—osteoporosis	7.65e-06	0.000197	CbGpPWpGaD
Mirabegron—ALB—Metabolism—POMC—osteoporosis	7.42e-06	0.000191	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—CYP19A1—osteoporosis	6.66e-06	0.000171	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—POMC—osteoporosis	6.5e-06	0.000167	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—POMC—osteoporosis	6.13e-06	0.000158	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—ADCY5—osteoporosis	5.44e-06	0.00014	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—GPX1—osteoporosis	5.43e-06	0.00014	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—MTHFR—osteoporosis	5.01e-06	0.000129	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—POMC—osteoporosis	4e-06	0.000103	CbGpPWpGaD
